Keywords: F1 + 2; aPTT; activated partial thromboplastin time; AT; antithrombin; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; F1Â +Â 2; prothrombin fragments F1Â +Â 2; FII; prothrombin; FVIII:C; factor VIII coagulant activity; IDDM; insulin-
مقالات ISI F1 + 2 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: F1 + 2; CVD; cardiovascular disease; USDA; United States Department of Agriculture; MUFA; monounsaturated fatty acids; GI; glycaemic index; MUFObes; Mono Unsaturated Fatty acids in Obesity; LF; low-fat; BMI; body mass index; FVII; factor VII; TAFI; thrombin activ
Keywords: F1 + 2; CAR; Central African Republic haplotype; ELISA; enzyme-linked immunosorbent assay; F1Â +Â 2; prothrombin fragment 1 and 2; Hb; hemoglobin; HbF; hemoglobin F percentage; HED; hemolysis-endothelial dysfunction subphenotype; LDH; lactate dehydrogenase; MRI;
Full Length ArticleThe causes of thrombocytopenia after transcatheter aortic valve implantation
Keywords: F1 + 2; F1Â +Â 2; prothrombin fragments 1Â +Â 2; MPV; mean platelet volume; PF-4; platelet factor 4; POD; postoperative day; PS; P-selectin; TAVI; transcatheter aortic valve implantation; Coagulation activation; Mechanisms of thrombocytopenia; Platelet activation
Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux
Keywords: F1 + 2; AUC5Â min; area under the curve of 5Â min-aggregation response; DMSO; dimethyl sulfoxide; F1Â +Â 2; prothrombin fragment F1Â +Â 2; FXa; factor Xa; IC50; 50% inhibition concentration; PPP; platelet-poor plasma; PRP; platelet-rich plasma; SEM; standard erro
Prothrombin fragment 1 + 2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism
Keywords: F1 + 2; CI; confidence interval; CT; computer tomography; DVT; deep vein thrombosis; ELISA; enzyme-linked immuno sorbent assay; F1Â +Â 2; prothrombin fragment 1Â +Â 2; IQR; interquartile range; NPV; negative predictive value; OCP; oral contraceptive pills; PAOI;
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation
Keywords: F1 + 2; APC; activated protein C; c.s; caesarean section; CV; coefficient of variation; DIC; disseminated intravascular coagulation; DVT; deep vein thrombosis; ELISA; enzyme-linked immunosorbent assay; FVL; Factor V Leiden; F1Â +Â 2; prothrombin fragments 1Â +Â 2
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Keywords: F1 + 2; Apo; apolipoprotein; BMI; body mass index; CV; coefficient of variation; CVD; cardiovascular disease; ELISA; enzyme-linked immunosorbant assay; F1Â +Â 2; protrombin fragment 1Â +Â 2; FH; familial hypercholesterolaemia; LDL; low density lipoprotein; PAI-1;
Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue
Keywords: F1 + 2; ABC; avidin - biotin complex technique; antibody T2G1; antibody directed to fibrin II (des fibrinopeptide B fibrin); antibody 1-8C6; antibody which reacts with fibrinogen or des fibrinopeptide A fibrin but not with des fibrinopeptide B fibrin; AT; antit
Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation
Keywords: F1 + 2; TAT; thrombin-antithrombin; F1Â +Â 2; prothrombin fragment F1Â +Â 2; PAI; plasminogen activator inhibitor; MP; microparticles; BMI; body mass index; NEFA; non-esterified fatty acids; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipoprot
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study
Keywords: F1 + 2; CITP; carboxy-terminal telopeptide of collagen type I; CRP; C reactive protein; CRT; Cardiac Resynchronization Therapy; F1Â +Â 2; Prothrombin fragment 1Â +Â 2; MMP-1; Matrix metalloproteinase-1; MMP-2; Matrix metalloproteinase-2; TIMP-1; Tissue inhibitor
Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection
Keywords: F1 + 2; NE; nephropathia epidemica; F1Â +Â 2; prothrombin fragments; APTT; activated partial thromboplastin time; PT; prothrombin time; TT; thrombin time; AT; antithrombin; PS; protein S free antigen; PC; protein C; CBC; complete blood count; DIC; disseminated in
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: A multicenter, randomized, double-blind study
Keywords: F1 + 2; HRT; hormone replacement therapy; SERM; selective estrogen receptor modulator; CCHT; continuous combined hormone therapy; FSH; follicle-stimulating hormone; FVII; factor VII; FVIII; factor VIII; F1Â +Â 2; prothrombin fragments 1 and 2; PAI; plasminogen ac
The APC-PCI complex concentration predicts outcome of aortic surgery
Keywords: F1 + 2; AAA; abdominal aortic aneurysm; APACHE II; Acute Physiology and Chronic Health Evaluation II; APC; activated protein C; APTT; Activated Partial Thromboplastin Time; CV; coefficient of variation; F1Â +Â 2; fragment 1Â +Â 2; ICU; intensive care unit; INR; I
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection
Keywords: F1 + 2; MNC; mononuclear cells; TF; tissue factor; PAI-2 and PAI-1; plasminogen activator inhibitor type 2 and type 1; TM; thrombomodulin; HP-NAP; H. pylori neutrophil-activating protein; TAFI; thrombin activatable fibrinolysis inhibitor; t-PA; tissue plasminogen